Granted Patent
B2
US 10,179,765 · App. 15/961,441 · Granted Jan 15, 2019
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
Inventors:
John P. Toscano (Glen Arm, MD); Frederick Arthur Brookfield (Abingdon, GB); Andrew D. Cohen (Mamaroneck, NY); Stephen Martin Courtney (Abingdon, GB); Lisa Marie Frost (Abingdon, GB); Vincent Jacob Kalish (Annapolis, MD)
C07C311/48C07C317/14C07C323/67C07D213/74C07D231/18C07D261/10C07D263/58C07D285/125C07D295/096C07D307/82C07D309/12C07D317/14C07D333/34C07D333/62
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.
Claims (2)
1. A compound which is
2. A compound which is
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 9, 2022
From: CARDIOXYL PHARMACEUTICALS INC.
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 062041/0565 →
Continuity (8)
Provisional Application
60783556
· Mar 17, 2006
Cited By (1)